A carregar...
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) effectively lower plasma glucose (PG) concentration in patients with type 2 diabetes, but studies have suggested that circulating glucagon concentrations and endogenous glucose production (EGP) are increased by SGLT2i, possibly compromising their gl...
Na minha lista:
| Publicado no: | Diabetes |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7679772/ https://ncbi.nlm.nih.gov/pubmed/33004472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db20-0369 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|